Zone Frontier Inc. (ZONE)
ZONE trades on NYSE in Consumer Discretionary, Specialty Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.1130
-3.58% on the day
Market cap
$57.5M
Micro cap
Revenue · 2025
$2.1M
+29.2% on 2024
Net income · 2025
-$6.7M
-325.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ZONE on NYSE |
| Sector | Consumer Discretionary |
| Industry | Specialty Chemicals |
| Country | Not reported by the screener |
| IPO year | 2024 |
| SEC CIK | 0001956741 |
| SEC industry code | Specialty Cleaning, Polishing and Sanitation Preparations |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.1M |
| Net income | -$6.7M |
| Operating income | -$6.4M |
| Net margin | -325.3% |
| Operating margin | -308.1% |
| Revenue growth | +29.2% |
| Cash | $5.4M |
| Total assets | $101.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 27.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-08-12 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-09-28 |
| Latest quarterly / interim AMENDMENT NO. 1 TO FORM 10-Q | 10-Q/A | 2026-05-18 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-30 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2025-10-28 |
Source: SEC EDGAR submissions feed, 189 recent filings. All filings on EDGAR.
Peers in Specialty Chemicals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NPT | Texxon Holding Limited | $2.27 | +3.18% | $50.4M |
| YHGJ | Yunhong Green CTI Ltd. | $2.67 | -1.11% | $7.0M |
| HWKN | Hawkins Inc. | $131.89 | +1.13% | $2.8B |
| ASH | Ashland Inc. | $72.65 | +2.64% | $3.3B |
| CLX | Clorox Company (The) | $84.45 | +0.12% | $10.2B |
| CSL | Carlisle Companies Incorporated | $328.85 | +2.90% | $13.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier